Literature DB >> 33842274

Suprarenal lymphadenectomy with nephrectomy for refractory ovarian cancer.

Soo Jin Park1, Hee Seung Kim1.   

Abstract

The effect of debulking surgery is not vague in patients with refractory ovarian cancer because of drug-resistant tumor biology showing rapid growth. However, it can be considered to be beneficial for selected patients expected to show tumor response by postoperative treatment because the better perfused small tumors may favor the action of cytotoxic therapy. Among them, patients with enlarged lymph nodes and BRCA mutations can show a relatively high rate of response and improved survival by systematic lymphadenectomy followed by poly ADP ribose polymerase (PARP) inhibitors. However, the resection of enlarged lymph nodes above the renal vein may not be familiar to gynecologic oncologists, in particular, for patients who had undergone previous debulking surgery followed by repetitive chemotherapy. Thus, this video will show the step by step procedure of suprarenal lymphadenectomy and en bloc resection of kidney and suprahilar lymph nodes for complete resection of refractory ovarian cancer. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Refractory ovarian cancer; nephrectomy; olaparib; suprarenal lymphadenectomy

Year:  2021        PMID: 33842274      PMCID: PMC8033076          DOI: 10.21037/gs.2020.04.08

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  11 in total

1.  Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

Authors:  Bella Kaufman; Ronnie Shapira-Frommer; Rita K Schmutzler; M William Audeh; Michael Friedlander; Judith Balmaña; Gillian Mitchell; Georgeta Fried; Salomon M Stemmer; Ayala Hubert; Ora Rosengarten; Mariana Steiner; Niklas Loman; Karin Bowen; Anitra Fielding; Susan M Domchek
Journal:  J Clin Oncol       Date:  2014-11-03       Impact factor: 44.544

Review 2.  Second-line treatment of ovarian cancer.

Authors:  M Markman; M A Bookman
Journal:  Oncologist       Date:  2000

Review 3.  Management strategies for recurrent platinum-resistant ovarian cancer.

Authors:  R Wendel Naumann; Robert L Coleman
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

Review 4.  Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer.

Authors:  Marianne J Rutten; Mariska M G Leeflang; Gemma G Kenter; Ben Willem J Mol; Marrije Buist
Journal:  Cochrane Database Syst Rev       Date:  2014-02-21

5.  Secondary debulking surgery for isolated para-aortic nodal recurrence in ovarian cancer involving the division of the left renal vein.

Authors:  Kazuyoshi Kato; Tomoka Usami; Nobuhiro Takeshima
Journal:  Gynecol Oncol       Date:  2015-02-11       Impact factor: 5.482

6.  Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution Experience.

Authors:  A Musella; C Marchetti; I Palaia; G Perniola; M Giorgini; F Lecce; L Vertechy; R Iadarola; F De Felice; M Monti; L Muzii; R Angioli; P Benedetti Panici
Journal:  Ann Surg Oncol       Date:  2015-03-24       Impact factor: 5.344

7.  Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: a retrospective analysis.

Authors:  M Petrillo; L Pedone Anchora; L Tortorella; F Fanfani; V Gallotta; M Pacciani; G Scambia; A Fagotti
Journal:  Gynecol Oncol       Date:  2014-06-05       Impact factor: 5.482

8.  Secondary debulking surgery in ovarian cancer patients with isolated nodal recurrence located in the region above and behind the renal vein.

Authors:  Kazuyoshi Kato; Kohei Omatsu; Nobuhiro Takeshima
Journal:  Gynecol Oncol       Date:  2013-04-02       Impact factor: 5.482

9.  Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II Study.

Authors:  Karina Dahl Steffensen; Parvin Adimi; Anders Jakobsen
Journal:  Int J Gynecol Cancer       Date:  2017-11       Impact factor: 3.437

10.  Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy.

Authors:  Maria Lee; Chel Hun Choi; Yi Kyeong Chun; Yun Hwan Kim; Kwang Beom Lee; Shin Wha Lee; Seung Hyuk Shim; Yong Jung Song; Ju Won Roh; Suk Joon Chang; Jong Min Lee
Journal:  J Gynecol Oncol       Date:  2016-08-19       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.